公开(公告)号：US20190083467A1

公开(公告)日：2019-03-21

申请号：US16083295

申请日：2017-03-09

申请人： TAKEDA PHARMACEUTICAL COMPANY LIMITED

发明人： Masaki OGINO ,  Eiji KIMURA ,  Shinkichi SUZUKI ,  Kouji FUJI ,  Tomohiro OHASHI ,  Makoto FUSHIMI ,  Kei MASUDA ,  Tatsuki KOIKE ,  Takeshi WAKABAYASHI ,  Jinichi YONEMORI ,  Masami YAMADA

IPC分类号： A61K31/4192 ,  A61K31/4155 ,  A61P25/16 ,  A61P25/18 ,  A61P25/20 ,  A61P25/28

摘要： Provided is a compound having a cholinergic muscarine M1 receptor positive allosteric modulator activity. A compound represented by the formula (I): wherein each symbol is as described in the DESCRIPTION, or a salt thereof has a cholinergic muscarine M1 receptor positive allosteric modulator activity, and is useful as a prophylactic or therapeutic drug for Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies and the like.